New treatments to prevent and manage neovascular glaucoma
Elucidation of novel anti-angiogenic therapies for the prevention and treatment of neovascular glaucoma
['FUNDING_R01'] · UNIVERSITY OF MARYLAND BALTIMORE · NIH-10929373
This study is looking for new ways to help people with neovascular glaucoma, an eye condition that can cause vision loss, by testing treatments that stop harmful blood vessel growth in the eye.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MARYLAND BALTIMORE (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10929373 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative therapies to prevent and treat neovascular glaucoma, a serious eye condition that can lead to blindness. It investigates the role of specific proteins that promote abnormal blood vessel growth in the eye, which can increase pressure and damage vision. By understanding the underlying mechanisms and testing new anti-angiogenic agents, the research aims to provide effective treatments that can be administered early to prevent severe complications. Patients may be involved in trials to evaluate the safety and effectiveness of these new therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with neovascular glaucoma or those at high risk due to underlying retinal diseases.
Not a fit: Patients with glaucoma not related to neovascularization or those without retinal ischemia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly reduce the risk of blindness in patients with neovascular glaucoma.
How similar studies have performed: Previous research has shown promise in using anti-angiogenic therapies for other eye conditions, suggesting potential success for this novel approach.
Where this research is happening
BALTIMORE, UNITED STATES
- UNIVERSITY OF MARYLAND BALTIMORE — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MONTANER, SILVIA V — UNIVERSITY OF MARYLAND BALTIMORE
- Study coordinator: MONTANER, SILVIA V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.